|
Indian Pediatr 2013;50: 970 |
|
Role of Zinc in Neonatal Sepsis: Emerging Data
|
Vikram Kumar and Rohit Arora
Department of Pediatrics, Fortis
Memorial Research Institute, Sector- 44 , Gurgaon, Haryana.
Email: [email protected]
|
The study conducted by Mehta, et al. [1] is indeed,
one of its own kind and has a good internal validity,
although following issues need attention
It is not mentioned on what basis a dose
for zinc (1 mg/ kg/day) was decided; and how the exact dose
of 1 mg/kg of zinc was administered in each infant by using
a 10 mg dispersable tablet (almost all weighing less than 3
kg). The safety of administering zinc to an infant who
needed to be nil per oral has also not been described. The
breast feeding status of the infants in the two groups have
not been mentioned. There is no mention of the average age
at which the infants were enrolled in the study. The
inclusion of other markers of infection like procalcitonin
and blood culture (BACTEC) would have given more specificity
in identifying sepsis patients. Some kind of sickness
assessment score (PRISM / CRIB) to determine the severity of
illness could help better understand the status of the given
cohort. Duration of antibiotic treatment is not clear. The
diagnosis of sepsis is described to be one of the three
criteria. However, in the absence of first two criteria the
presence of only third criteria is unlikely to warrant the
need of antibiotics as X-ray findings could be
non-specific for neonatal pneumonia.
Studies have shown that zinc
supplementation is benificial in reducing the mortality of
small for gestation age (SGA) infants [2]. It will be
prudent to sub-group the cohort as appropriate for
gestational age (AGA) and SGA and then analyse the results.
Demographic, clinical, microbiological data of the infants
who died need to be compared with the rest of the group.
In a recently published multicentric
randomized controlled trial (RCT) by Bhatnagar, et al.
[4] the authors
reported that zinc reduced treatment failure (defined as a
need to change antibiotics within 7 days of randomization,
or a need for intensive care, or death at any time within 21
days) in infants younger than 120 days with probable serious
bacterial infection by 40%. These promising results are
contrary to that seen by the authors [1].
References
1. Mehta K, Bhatta NK, Majhi S,
Shrivastava MK, Singh RR. Oral zinc supplementation for
reducing mortality in probable neonatal sepsis: A double
blind randomized placebo controlled trial. Indian Pediatr.
2013;50:390-3.
2. Sazawal S, Black RE, Menon VP, Dinghra
P, Caulfield LE, Dhingra U, et al. Zinc
supplementation in infants born small for gestational age
reduces mortality: a prospective, randomized, controlled
trial. Pediatrics. 2001;108:1280-6.
3. Bhatnagar S, Wadhwa N, Aneja S, Lodha R, Kabra SK,
Mouli Natchu UC, et al. Zinc as adjunct treatment in
infants aged between 7 and 120 days with probable serious
bacterial infection: a randomised, double-blind,
placebo-controlled trial. Lancet. 2012;379:2072-8.
|
|
|
|